Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Apyx Medical (APYX) Receivables Refunds (2019 - 2023)

Apyx Medical (APYX) has disclosed Receivables Refunds for 5 consecutive years, with $7.8 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Receivables Refunds rose 1.44% year-over-year to $7.8 million, compared with a TTM value of $7.8 million through Jun 2023, up 1.44%, and an annual FY2022 reading of $7.5 million, down 1.27% over the prior year.
  • Receivables Refunds was $7.8 million for Q2 2023 at Apyx Medical, roughly flat from $7.8 million in the prior quarter.
  • Across five years, Receivables Refunds topped out at $7.8 million in Q1 2023 and bottomed at $426000.0 in Q4 2019.
  • Average Receivables Refunds over 5 years is $6.9 million, with a median of $7.6 million recorded in 2021.
  • The sharpest move saw Receivables Refunds soared 1696.71% in 2020, then fell 1.42% in 2022.
  • Year by year, Receivables Refunds stood at $426000.0 in 2019, then skyrocketed by 1696.71% to $7.7 million in 2020, then dropped by 0.16% to $7.6 million in 2021, then decreased by 1.27% to $7.5 million in 2022, then increased by 2.74% to $7.8 million in 2023.
  • Business Quant data shows Receivables Refunds for APYX at $7.8 million in Q2 2023, $7.8 million in Q1 2023, and $7.5 million in Q4 2022.